Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.

2016

Objective: Topoisomerase 1 (topo-1) is an important target for the treatment of metastatic colorectal cancer (CRC). The aim of the present study

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

25

References

3

Citations